PRAGUE-25 Trial. Catheter Ablation vs. AADs and Risk Factor Modification.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 212 participants.
Also called NCT04011800
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 212 participants
- Registry
-
NCT04011800
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Czechia
- Registry status
- Unknown status
Technical summary
Registry record NCT04011800. Randomized; no masking; primary purpose treatment. Start 2021-05-01 (actual); primary completion 2025-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PRAGUE-25 Trial. Catheter Ablation vs. AADs and Risk Factor Modification.
- Condition
- Atrial Fibrillation
- Intervention (Procedure)
- Catheter ablation
- Intervention (Combination product)
- Risk Factor Modification
- Lead sponsor
- Charles University, Czech Republic
- Collaborator
- General Teaching Hospital, Prague
- Collaborator
- Brno University Hospital
- Collaborator
- Hospital Podlesi
- Collaborator
- Regional Hospital Liberec
Record details
- Record id
cardio:ct-nct04011800- Content hash
66e3817f4c66b9ae938cca5c5b4ab7ab2558cfec1161d20c158f30e81b44c011